Increased one-year continuation of DMPA among women randomized to self-administration: Results from a randomized controlled trial at Planned Parenthood
Contraception Dec 20, 2017
Kohn JE, et al. - Researchers here perform a comparison of one-year continuation of subcutaneous depot medroxyprogesterone acetate (DMPA-sc) between women randomized to self-administration vs clinic administration. Observations reveal that self-administration of subcutaneous DMPA improves contraceptive continuation and is a feasible and acceptable option for women and adolescents
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries